Maples advised MicroPort Scientific Corporation on the offering.
MicroPort Scientific Corporation executed an issuance of US$700 million aggregate principal amount of zero coupon convertible bonds due 2026.
The Bonds will, at the option of the holder, be convertible on or after 22 July 2021 until and including 1 June 2026 into fully paid ordinary shares of par value of US$0.00001 each in the issued and paid up capital of the Issuer at an initial conversion price of HK$92.8163 per Share. The Issuer is a leading medical device group focusing on developing, manufacturing and marketing high-end medical devices globally.
The Maples team was led by partner Lorraine Pao (Picture) and associate Alicia Phang.
Law Firms: Maples and Calder;
Clients: MicroPort Scientific Corporation;